榴莲视频

Charles Bankhead

Charles Bankhead

Authors >

Charles Bankhead

Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. His career spans more than 30 years, including a decade with Medical World News, a leading medical trade magazine of its time. He had a long and successful freelance career before joining 榴莲视频 in 2007. Charles graduated with honors from Texas Tech University, receiving a BA in journalism, and completed a master's degree in mass communication, with specialization in health communication, also at Texas Tech.

Connect:

email image

Latest from Charles Bankhead

A photo of test tubes of blood lying on a test form with CANCER stamped in red at the bottom.

Cancer Diagnoses Slow to Recover From Effects of COVID Pandemic

Actual rates for 2021 lagged behind projections

A photo of red blood cells and activated platelets trapped in fibrin.

Gene Therapy for Hemophilia B Significantly Outperforms Factor IX Prophylaxis

Fidanacogene elaparvovec reduces bleeding episodes by 71% after a single infusion

FDA ODAC PD-(L)1 inhibitors over a computer rendering of esophageal cancer

Immunotherapy May Not Benefit All Gastroesophageal Cancer Patients, FDA Staff Says

Data since approvals suggest benefits limited to subgroups with PD-L1 expression of at least 1%

A computer rendering of lymphocytes attacking cancer cells.

Turning 'Cold' Tumors Into 'Hot' Tumors

Adoptive cell therapy, bispecific antibodies, novel immunotherapies among numerous strategies

Onco Break over a computer rendering of a cancer cell.

Earlier Info on Financial Stress; Obesity and Second Cancers; Carcinogenic Condoms?

News, features, and commentary about cancer-related issues

ESMO over a photo of Fira Barcelona Gran Via in Barcelona, Spain.

Rucaparib-Nivolumab Maintenance Not the Answer in Newly Diagnosed Ovarian Cancer

Poorer survival outcomes plus more toxicity versus rucaparib alone

ESMO over a photo of Fira Barcelona Gran Via in Barcelona, Spain.

Survival Win for Pembrolizumab in Early Triple-Negative Breast Cancer

Absolute difference of 4.9% at 5 years, including a benefit for patients who did not achieve pCR

ESMO over a photo of Fira Barcelona Gran Via in Barcelona, Spain.

Another Possible Treatment Option for Intermediate-Stage Liver Cancer

Adding lenvatinib, pembrolizumab to TACE significantly improved PFS, numerically improved OS

ESMO over a photo of Fira Barcelona Gran Via in Barcelona, Spain.

Radionuclide-Containing Combo Slows Metastatic Prostate Cancer, Improves Survival

Hazards for radiographic PFS, OS reduced by 31% with enzalutamide plus Ra-223

A photo of a woman holding Apple AirPods Pro.

FDA OKs Software to Convert Apple AirPods Into Hearing Aids

Designed for certain models, software can customize audio parameters

鈥�

6

鈥�